UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Extensive Arterial, Venous and Intracardiac Thrombosis in a Patient After Recovery From COVID-19

Clinical and applied thrombosis/hemostasis, 2021-11, Vol.27

2021

Volltextzugriff (PDF)

Disseminated Coccidioidomycosis in an Immunocompetent Male Who Lived in an Endemic Region in the Remote Past: A Case Report

Curēus (Palo Alto, CA), 2022-05

2022

Volltextzugriff (PDF)

Adult-Onset Immunoglobulin A Vasculitis With Renal Involvement

Curēus (Palo Alto, CA), 2022-03

2022

Volltextzugriff (PDF)

Metformin-Associated Lactic Acidosis in a Patient With CKD: PUB356

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.983-983

2022

Volltextzugriff (PDF)

Remdesivir use in COVID‐19 patients with end‐stage kidney disease on intermittent hemodialysis: An absolute contraindication?

Therapeutic apheresis and dialysis, 2022-08, Vol.26 (4), p.850-851

2022

Volltextzugriff (PDF)

Efficacy and Safety of Daprodustat for Treatment of Anemia in CKD: A Meta-Analysis: TH-PO689

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.243-243

2022

Volltextzugriff (PDF)

Level of Employers' Satisfaction on the Employees' Performance at the Irbid Industrial Zone in Jordan

International journal of academic research in economics and management sciences, 2016-12, Vol.5 (4)

2016

Volltextzugriff (PDF)

Reasons for extraction of permanent teeth in Jordan

International dental journal, 1999-12, Vol.49 (6), p.343-346

1999

Volltextzugriff (PDF)

America’s Commercial Cold War: Global Trade, National Security, and the Control of Markets

Haddad, Ryan Issa

2020

Volltextzugriff (PDF)

Extensive Arterial, Venous and Intracardiac Thrombosis in a Patient After Recovery From COVID-19

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2021, Vol.27, p.10760296211059495-10760296211059495

2021

Volltextzugriff (PDF)

Temporomandibular joint osteoarthrosis. Histopathological study of the effects of intra-articular injection of triamcinolone acetonide

Saudi medical journal, 2000-07, Vol.21 (7), p.675

Haddad, I K

2000

Volltextzugriff (PDF)

Sickle cell cholangiopathy： An endoscopic retrograde cholangiopancreatography evaluation

World journal of gastroenterology : WJG, 2009-11, Vol.15 (42), p.5316-5320

Hussain Issa Ali AI-Haddad Ahmed AI-Salem

2009

Volltextzugriff (PDF)

Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells

PloS one, 2008-04, Vol.3 (4), p.e2037

2008

Volltextzugriff (PDF)

Reply to “Impact of obesity surgery on tyrosine kinase inhibitor responses and survival outcomes in patients with chronic myeloid leukemia: Further data are still warranted!”

Cancer, 2023-07, Vol.129 (14), p.2268-2268

2023

Volltextzugriff (PDF)

The presence of additional cytogenetic abnormalities (ACAs) or Philadelphia chromosome variants do not adversely affect the achievement of treatment‐free remission in chronic myeloid leukemia

American journal of hematology, 2024-06, Vol.99 (6), p.1175-1176

2024

Volltextzugriff (PDF)

The outcomes of patients with chronic myeloid leukemia treated with third‐line BCR::ABL1 tyrosine kinase inhibitors

American journal of hematology, 2023-04, Vol.98 (4), p.658-665

2023

Volltextzugriff (PDF)

Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre- and post-ponatinib era

American journal of hematology, 2023-10, Vol.98 (10), p.1619-1626

2023

Volltextzugriff (PDF)

Ponatinib for the treatment of adult patients with resistant or intolerant Chronic-Phase Chronic Myeloid Leukemia

Expert opinion on pharmacotherapy, 2022-05, Vol.23 (7), p.751-758

2022

Volltextzugriff (PDF)

Treatment‐free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors

American journal of hematology, 2022-07, Vol.97 (7), p.856-864

2022

Volltextzugriff (PDF)

Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients

The New England journal of medicine, 2019-04, Vol.380 (17), p.1606-1617

2019

Volltextzugriff (PDF)

Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase

Cancer, 2024-10, Vol.130 (19), p.3344-3352

2024

Volltextzugriff (PDF)

Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia?

Leukemia, 2024-05, Vol.38 (5), p.947-950

2024

Volltextzugriff (PDF)

Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements

Blood cancer journal (New York), 2021-09, Vol.11 (9), p.162-10, Article 162

2021

Volltextzugriff (PDF)

Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemia

Cancer, 2024-08, Vol.130 (15), p.2652-2659

2024

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(104)

Publikationsform

Sprache

Englisch
(129)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(54)
Humans
(41)
Hematology
(28)
Adult
(22)
Female
(22)
Male
(21)
Middle Aged
(20)
Oncology
(18)
Aged
(17)
Leukemia
(17)
Chronic Myeloid Leukemia
(14)
Myeloid Leukemia
(13)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(11)
Survival
(10)
General & Internal Medicine
(9)
Medicine, General & Internal
(9)
Treatment Outcome
(9)
Tyrosine Kinase Inhibitors
(9)
Adolescent
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Extensive Arterial, Venous and Intracardiac Thrombosis in a Patient After Recovery From COVID-19

Disseminated Coccidioidomycosis in an Immunocompetent Male Who Lived in an Endemic Region in the Remote Past: A Case Report

Adult-Onset Immunoglobulin A Vasculitis With Renal Involvement

Metformin-Associated Lactic Acidosis in a Patient With CKD: PUB356

Remdesivir use in COVID‐19 patients with end‐stage kidney disease on intermittent hemodialysis: An absolute contraindication?

Efficacy and Safety of Daprodustat for Treatment of Anemia in CKD: A Meta-Analysis: TH-PO689

Level of Employers' Satisfaction on the Employees' Performance at the Irbid Industrial Zone in Jordan

Reasons for extraction of permanent teeth in Jordan

America’s Commercial Cold War: Global Trade, National Security, and the Control of Markets

Extensive Arterial, Venous and Intracardiac Thrombosis in a Patient After Recovery From COVID-19

Temporomandibular joint osteoarthrosis. Histopathological study of the effects of intra-articular injection of triamcinolone acetonide

Sickle cell cholangiopathy： An endoscopic retrograde cholangiopancreatography evaluation

Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells

Reply to “Impact of obesity surgery on tyrosine kinase inhibitor responses and survival outcomes in patients with chronic myeloid leukemia: Further data are still warranted!”

The presence of additional cytogenetic abnormalities (ACAs) or Philadelphia chromosome variants do not adversely affect the achievement of treatment‐free remission in chronic myeloid leukemia

The outcomes of patients with chronic myeloid leukemia treated with third‐line BCR::ABL1 tyrosine kinase inhibitors

Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre- and post-ponatinib era

Ponatinib for the treatment of adult patients with resistant or intolerant Chronic-Phase Chronic Myeloid Leukemia

Treatment‐free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors

Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients

Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase

Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial

Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia?

Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements

Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemia

Suchergebnisse filtern